Trial to Evaluate CIS43LS in Healthy Adults

NCT04206332 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

71

Enrollment

NIH

Sponsor class

Conditions

Malaria

Interventions

DRUG: VRC-MALMAB0100-00-AB
OTHER: Plasmodium falciparum (P. falciparum) sporozoite challenge

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)